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Abstract
Background: Human fascioliasis (HF) is a zoonotic disease that has been identified in many countries worldwide.
This report concerns the identification and clinical management of cases of human fascioliasis in the suburbs of
Arusha city, northern Tanzania in 2013. Fascioliasis is included among the WHO’s Neglected Tropical Diseases as a
plant transmitted trematode infection. Human fascioliasis has not been described before in the East Africa region,
including Tanzania.
Methods: Patients presenting at a primary healthcare centre in Arusha Region, northern Tanzania provided fresh
stool samples for routine ova and parasite screening (saline and iodine preparations). Subsequent stool samples
were preserved in 5 % formalin in saline and subjected to ether sedimentation for examination.
Results: Out of 1460 patients, 305 (21 %) were diagnosed positive for fascioliasis based on the demonstration of
brownish, oval eggs with inconspicuous opercula in stool. Two distinct egg sizes were identified; large 170–212.5
by 115–150 μm (mean 194.5 by 130.5 μm) and smaller eggs 120–150 by 87.5 – 112.5 μm (mean 138.8 by 101 μm).
Clinically, patients presented with fever (39 - 40 °C) and abdominal pain. Some patients had pruritis around the
mouth and their lips were swollen. 3 patients were treated and cured with single dose Triclabendazole. The
remaining 302 patients were treated with Nitazoxanide and 122 (40 %) were cleared of infection with a single
course. Snails of the genus Lymnaea were found in the surroundings.
Conclusions: This report serves to remind medical professionals in East Africa that HF is a probable differential
diagnosis in patients presenting with similar symptoms. It is possible to diagnose fascioliasis by light microscopy
although specific antigen tests are required for confirmation. Human fascioliasis however, has not been described
or reported in Tanzania before and begs further investigation.
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Background
Fasciola hepatica and F. gigantica are trematodes com-
monly referred to as the liver flukes in sheep, goats and
cattle where they cause serious disease with significant
economic losses to farmers. Humans become infected
with the Fasciola by ingesting metacercariae encysted on
leaves of vegetables including watercress, radishes, corn,
spinach, alfalfa and broccoli [1]. Humans can also be-
come infected with Fasciola metacercariae in water
when drunk. Adult liver flukes are found in the bile
ducts and liver parenchyma of infected human and ani-
mal hosts. Fasciola cannot be passed directly from one
person to another [2]. Eggs passed in stool of infected
hosts hatch into miracidia which need freshwater lym-
naeid snail vectors to develop to sporocysts, rediae and
cercariae which leave the snail intermediate host and en-
cyst on leaves of vegetation as the infective metacercar-
iae [1–3]. After ingestion, juvenile flukes are released
from the metacercariae in the small intestine, having
survived stomach acid digestion. They penetrate the in-
testinal wall and migrate through the abdominal cavity,
the liver capsule and into the liver parenchyma.
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Following the penetration of the capsule the immature
flukes migrate through the liver tissues for about 6–8
weeks in the case of F. hepatica and up to 12–14 weeks
for F. gigantica, finally entering the bile ducts where they
mature and begin egg production [3, 4].
Human fascioliasis (HF) is usually asymptomatic,
though symptoms may occur early on in the infection
when immature flukes migrate from the intestine
through the abdominal cavity and liver. Symptoms asso-
ciated with HF are generally non-specific and can be cat-
egorized as acute and chronic. Symptoms of the acute
disease can start 4 to 7 days after infection characterized
by fever, nausea, malaise and abdominal pain. Less often
patients may present with urticaria as well as subcutane-
ous nodules [3, 4]. The chronic phase of the infection
occurs much later, usually 12 to 16 weeks after infection,
when adult flukes have settled in the bile ducts. On clin-
ical examination a tender or non-tender hepatomegaly
may be found. The symptoms of chronic disease may
last for months to years after infection, usually resulting
from inflammation and blockage of bile ducts. This is
usually complicated by biliary colic, cholestasis or chol-
angitis in untreated patients [5, 6].
The rather distinct and rare ova in stool samples of
various patients visiting TotalCare Medical Centre was
first noticed in April 2012. At the time, it was a rather
common finding to have high infection rates of Ancylos-
toma duodenale, Giardia lamblia as well as Entamoeba
histolytica in stool samples examined for parasitic infec-
tions. By mid-September 2012, many patients presented
with clinical symptoms suggestive of typhoid fever or in-
testinal worm infections. When stool from these patients
was examined microscopically, eggs with unfamiliar
brownish, oval appearance and inconspicuous opercu-
lum were observed; this was usually accompanied by
supporting biochemical and serological findings, where
analyzed.
Studies conducted within the northern Africa region
showed the epidemiological picture of human fascioliasis
to have changed in recent years. The number of reports
of humans infected with fascioliasis has increased signifi-
cantly since the 1980s and several geographical areas
have been described as endemic for the disease in
humans [2, 4–13].
Literature cited on HF in Africa showed that both
prevalence and intensity of infection were significantly
higher among girls than boys, with the highest preva-
lence and intensity of infection being reported in the 9–
11 years age group. Women were more affected than
men, but not at a significant level [9–11]. Many Fasciola
infected children were also co-infected by other parasites
[10–12]. The clinical diagnosis of fascioliasis depends
largely on the microscopic examination of stool samples
for ova by finding eggs with an inconspicuous
operculum [1, 3, 5]. Specific coprologic antigen tests
have recently been developed to determine the species
of Fasciola in clinical and field studies [12–15]. Immu-
nodiagnostic techniques using recombinant Fasciola
hepatica cathepsin L 1cystine proteinase, purified ca-
thepsin L cystine proteinase, and cathepsin L-ELISA
have been used to diagnose HF especially in the pre-
patent acute phase of disease [13–17]. In human in-
fection the drug of choice is Triclabendazole because
it has been noted to have the highest efficacy against both
the migratory juvenile and adult stages. In many areas
with scarce supply of Triclabendazole, Nitazoxanide has
also been used with differing success [18]. By mid- Sep-
tember 2012, many patients presented with clinical symp-
toms suggestive of fascioliasis. Tanzania and East Africa at
large have also had various reports on animal fascioliasis
and its management [19].
This report concerns the clinical and parasitological
findings of cases of HF at TotalCare Medical Centre, a
private, primary healthcare facility located in Themi Hill,
Arusha region, Tanzania. Consequent to various treat-
ment attempts with Nitazoxanide, as of October 2013,
many re-infections occurred. These cases were rather
evenly spread demographically including age, sex, social-
economic background and race of people living in the
Themi Hill surroundings, which has a notably high, sea-
sonal population of various snail species, particularly of
the family Lymnaeidea.
Many local inhabitants of the area use man-made deep
water wells and natural streams as a source of water for
domestic consumption. During the seasonal rains, the
area is subject to flooding and soggy, marshy soils espe-
cially towards the lower lying residential areas.
Methods
Ethical approval
This study was approved in July of 2012 by the health
management team of TotalCare Medical Centre as an
in-house clinical case study. In the conduct of this study,
compliance to good clinical practice as defined by the
Helsinki Declaration was observed. All subjects involved
provided written informed consent. Children’s parents
offered the consent on behalf of their children as
expressed in the Declaration of Helsinki.
Clinical
Most patients presenting at the clinic complained mainly
of high grade fever (39 - 40 °C), abdominal pain at the
upper right quadrant area and malaise. No abnormality
was detected on abdominal examination. Few of these
patients also presented with complaints of pruritis
around the mouth with swelling of the lips. Jaundice was
also observed. In clinical practice such presentation
would range from malaria, typhoid fever to urinary tract
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infection (UTI). Laboratory investigations commonly or-
dered were blood smear for malaria parasites, Widal test
for typhoid fever and urinalysis. Patients were provided
with stool containers containing 5 % formalin diluted in
saline as a preservative.
Clinical management
The clinical management of patients in the beginning of
this study was punctuated by apparent uncertainty and
lack of conclusive laboratory diagnosis of human fasciol-
iasis in our setting. Nevertheless, following a cautious
approach and exhaustive research on fascioliasis, we
came up with a reliable management protocol for pa-
tients diagnosed with human fascioliasis.
Three of the 305 patients were treated with Triclaben-
dazole administered at 10–12 mg/kg, which cleared the
patients of Fasciola infection. The remaining 302 were
treated with Nitazoxanide at a dose of 500 mg twice
daily for 6 days in adults and 200 mg twice daily for
3 days in children older than 4 years. Only 125 patients
were cleared of infection.
Laboratory diagnosis
Patients presenting at the outpatient department (OPD)
were asked to provide a stool sample on day 1, 3 and 6
for the qualitative diagnosis of parasite infection. Sample
collection and processing protocol was as recommended
by Cheesbrough [20]. Briefly, for fresh samples stool in a
clear transparent container was processed within 30 min
of collection. A plastic scoop provided with the stool
container was used to sample the edges and core of the
specimen, collecting approximately 0.5 gm of feces. This
was mixed to homogeneity in 10 microlitre saline on a
glass slide. A drop of 1 % iodine was placed on the ho-
mogenized fecal preparation and a coverslip applied. Io-
dized preparations were quickly examined under the
light microscope for identification of parasite eggs/ova at
×100 and ×400 magnification.
Subsequently, patients who received anthelminthic
treatment were provided with 50 ml stool containers
containing 5 ml of 5 % formalin diluted in saline as a
preservative. They were instructed on how to collect the
stool sample, typically a scoop full or approximately 5gm
to be mixed with the preservative and the cover sealed
tight. The sample was then brought to the laboratory the
following day. This protocol was routinely followed and
proved to be useful when patients were treated with
anthelminthics to assess effect of treatment.
Briefly, the stool was mixed to homogeneity in the pre-
servative (5 % formalin in saline). Ether (2 ml) was then
added to the homogenate and mixed thoroughly. The
mixture was then left to stand for 20 min before a sam-
ple of the sediment and the supernatant was collected
for examination. Approximately 0.02 ml sample was
placed at the centre of a microscope slide and a drop of
iodine added. A cover slip was placed over the mixture,
and the slide examined at x100 and x400 magnification.
A graduated reticle inserted in the objective piece was
first calibrated against the stage micrometer for
standardization. Egg size estimations were then made at
×100 magnification, and pictures taken at ×400 magnifi-
cation for clarity of features.
Repeat stool samples were taken day 3, 6, 14 and 21
post-therapy to screen for the presence of ova or para-
sites. When a diagnosis of fascioliasis was tentatively
reached, all samples suspected to have eggs were stored
at 2-8 °C and transported to the reference laboratory at
the Kilimanjaro Christian Medical University College for
confirmation of the diagnosis. In cases of mixed infec-
tions, patients were first managed for other infections.
Examination of stools for earlier suspected Fasciola eggs
was started after confirmation of treatment for co-
infections. This served as a further quality control
method for the diagnosis arrived at.
The data was then analyzed using descriptive statistics.
Results
The majority of patients attending the clinic (96 %) were
from the Themi-Njiro area (living within 2-10 km of the
clinic), in Arusha municipality, Tanzania. A few patients
also came from other municipalities outside Arusha.
Children below 12 years were the most often diagnosed
with fascioliasis (45 %).
Blood smears were mostly negative for haemo-
parasites, including malaria, but showed eosinophilia.
The Widal test for typhoid fever was positive in some
patients with titres of 1:160. Urinalysis was negative for
bacterial infection but showed moderate bilirubinuria.
Stool examination showed presence of oval Fasciola eggs
along with Ancylostoma duodenale eggs or Strongyloides
stercoralis larvae. Most of these were treated with Alben-
dazole and effect of treatment was observed for 2 weeks
after completion of medication. During this treatment
period though, patients who had initially presented with
urticaria worsened.
Oval Fasciola eggs (Figure 1) were demonstrated in
305 out of 1460 stool specimens. We reviewed 50 sam-
ples fixed in 5 % formalin in saline and stored for 1 week
at 2-8 °C. Two distinct egg size patterns were noted;
large ovoid eggs 170–212.5 by 115–150 μm (mean 194.5
by 130.5 μm) and a smaller egg range of 120–150 by
87.5 – 112.5 μm (mean 138.8 by 101 μm).
A snail of the genus Lymnaea, found in a natural water
source around the study area is presented in Fig. 2. Sex
and age distribution of the patients diagnosed with fas-
cioliasis and the annual distribution of cases diagnosed
at TotalCare Medical Centre are shown in Figs. 3 and 4
respectively.
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The results of stool examination for Fasciola eggs be-
fore and after treatment as well as re-infection after
treatment are given (see Flow Chart). 305 samples out of
1460 tested positive for Fasciola eggs in stool. Out of
these 103 (34 %) were males and 202 (66 %) were fe-
males. 138 (45 %) were below 12 years old. All 3 patients
treated with Triclabendazole were cured. 134 patients
out of 302 returned for stool examination within a two
week period after treatment with Nitazoxanide; 83
(62 %) of these were below the age of 12 years (data not
shown); 122 patients were cleared of infection with sin-
gle dose Nitazoxanide of whom 67 (55 %) were below
12 years old. 36 patients out of the 302 treated with
Nitazoxanide manifested severe reaction to the drug
which necessitated discontinuation; 25 (69 %) of these
were female with only 8 (22 %) below 12 years (data not
presented in the chart). After successful treatment
confirmed by re-examination of stool samples for eggs
over a 2 week period, 42 of the original 305 patients
were re-infected with Fasciola at varying time intervals
during the study period (12 months); 29 (69 %) of these
42 patients were children in the high risk age group i.e.
below 12 years (data not shown).
Other laboratory procedures performed and data ana-
lysis are presented in Table 1 and Table 2 below . They
included urinalysis, blood sugar, liver enzymes and cell
blood count. The comment column represents signifi-
cant findings
Fig. 1 a and b Eggs of Fasciola (a, small size; 130.5 by 102 μm and b, large 205 by 148 μm) as seen in an iodine stained stool sample after
formol-ether sedimentation. Original magnification x400 (arrow indicates position of the inconspicuous operculum; bar scale = 50 μm and 75 μm)
Fig. 2 A snail of the genus Lymnaea, one of the snails which act as
intermediate host of Fasciola on a piece of vegetation from a
natural stream
Fig. 3 Frequency of occurrence of fascioliasis in males and females
stratified from 1 to 11 years based on stool examination
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Discussion
Animal fascioliasis is a liver disease of ruminants which
has been described in many parts of the world including
a few African countries [1–5, 7–12]. Recently, human
fascioliasis has also been described as a zoonosis ac-
quired from domestic animals. Human fascioliasis is ac-
quired by the ingestion of Fasciola metacercariae
encysted on vegetables or in drinking water. The distri-
bution of human fascioliasis has recently been reported
in four African countries including; Egypt, Ethiopia,
Cameroon and South Africa. In most rural African set-
tings, domestic animals including cattle, sheep and goats
are part of agricultural activities, for provision of meat,
milk and hide. Similarly, in these settings, vegetables in-
cluding lettuce, radishes, corncob, alfalfa, and amaranths
are cultivated to provide vegetable food source. Rural
and semi - rural African settings readily provide the
environment suitable for the completion of the life
cycle of animal fascioliasis, which includes infected
animals that would release infective eggs into the
Fig. 4 Frequency of diagnosis of fascioliasis in males and females of
all age groups from September 2012 to October 2013
Flow Chart Showing Results of stool examination of 1460 stool samples for Fasciola eggs (pre- and post- treatment and effect of treatment).
*Side effects of Nitazoxanide were noticed more frequently and severely among females than males (data not shown). All patients presented
with abdominal pain (day 2–4), diarrhea (day 2–3), pharyngitis and flu-like syndrome (day 2–6) of treatment. In a few patients with pruritis, swelling
and rashes of hands and feet was observed
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environment and the subsequent development of cer-
cariae within Lymnaea snails, up to development of meta-
cercaria which encyst on vegetable leaves. When human
and animal fascioliasis concur the transmission cycle of
fascioliasis is amplified many fold.
The suburbs of Arusha city, where this study was con-
ducted, provide a scenario described above for efficient
transmission of animal fascioliasis to humans, i.e. the
agricultural system in this area includes cattle, sheep and
goats and vegetables are cultivated in abundance as an
additional food source. Additionally, some of the inhabi-
tants drink untreated water from natural streams.
In our case series, which involved 1460 persons over a
12 month period, 305 (21 %) were found to be infected
with fascioliasis. Because Fasciola eggs are not detected
during the acute infection, and because the disease has
not been described before in Tanzania, it is likely that la-
boratory investigations intended to detect intestinal
worm infections in stool would have missed the recogni-
tion of Fasciola eggs in the stool samples.
We also observed two distinct egg sizes on micro-
scopic examination: large ovoid eggs mean 194.5 by
130.5 μm and smaller oval eggs mean 138.8 by 101 μm,
which correspond to reported egg size ranges for fascio-
lid eggs [1, 5]. The eggs recovered in this study are not-
ably wider than reported egg size ranges for both F.
hepatica and F. gigantica from other reports [1, 21].
This could be due to preservation in 5 % formalin in sa-
line (for 1 week) before measurements were taken. It
could also be a slight variation is egg size for this region
as no previous studies have reported the infection char-
acteristics among humans, and egg sizes have been
noted to vary according to geographical location [1, 5, 21].
The presence of two distinct egg sizes, sometimes recov-
ered from stool samples of the same patient also point to
possible co-infection by the different species, and may fur-
ther insinuate the possibility of hybrid species [21, 22]. Al-
though we were unable to speciate the causative parasite
as being Fasciola hepatica or F. gigantica in this particular
clinical study, other veterinary and malacology studies
conducted in the region and East Africa in general [19, 22,
23] have shown the presence of both species. The climatic
and demographic distribution of the two species has been
highlighted [21–23] and of note is the presence of both
species in certain geographical regions, subject to altitude
and fresh water availability. Because Fasciola eggs have an
Table 1 Results of other laboratory procedures done






Urinalysis for Bilirubin using Uriscan Optima analyser on 10SGL sticks 290 95 Bilirubin concentration varied from 0.5 – 1.0 mg/dL
for most patients interpreted as mild bilirubinuria
Stool examination for protozoa including Entamoeba histolytica, Giardia
lamblia. Worms including A.duodenale, A. lumbricoides and Strongyloides
stercoralis
302 99 Of 305 samples
Intestinal worms 140 (46 %)
E. histolytica 109 (36 %)
G. liamblia 55 (18 %)
Sterco-brown, loosely formed stools, fatty or mucoid with blackish
exudates.
302 99 Very common
Table 2 Results of Hematology and Biochemistry tests done
Test Procedure done and tools used Number tested
out of 305
Recorded readings Normal Ranges
Blood sugar test using one-touch auto test kit 198 Fasting 5.5 mmol/L Fasting 2.0 – 4.0 mmol/L
Random 12.0 mmol/L Random 3.5 – 7.0 mmol/L
Liver enzymes/function tests using Statfax Chemwell a
uto analyser
152 AST 50–65 U/L AST <50 U/L
ALT 55–65 U/L ALT < 45 U/L
Direct Bilirubin 0.6-0.9 mg/dL Direct Bilirubin 0.2-0.4 mg/dL
Haematology complete blood picture including Hb, levels of MCV,
MCH & MCHC; using D-Cell 30 auto haematology 3 index analyser
207 Eosinophils 0.6-1.4 % Eosinophilis <0.4 %
Hb 9.5-11 g/dL Hb 11–14 g/dL
MCV 60–66 fL MCV 70 fL
MCH 20–26 g/dL MCH 32.5 g/dL
* Amino transferases, were slightly elevated (normal ranges AST <46 U/L, ALT < 50 U/L)
** Direct bilirubin (normal range <0.5 md/dL) was markedly raised. *** In some patients the eosinophilia was highly marked
****The MCV and MCH concentrations were markedly below the normal range. Normal ranges for random blood sugar (3.5 – 5.5 mmol/L), Hb (11.0 – 14.0 g/dL)
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inconspicuous operculum, it is difficult for the unsuspect-
ing investigator to identify them with certainty, even in
well documented endemic regions [1–3, 5–8].
Triclabendazole is the drug of choice for the treatment
of both animal and human fascioliasis as noted in other
studies [12, 18]. In this study, three patients were cleared
of HF by a single dose of this drug. Use of Nitazoxanide
did not clear all patients treated. This finding was con-
sistent with some earlier reports.
This study has shown that more females than males
are infected with HF and that fascioliasis is quite often
associated with children below 12 years in both sexes.
This finding is in agreement with what has been previ-
ously reported about the epidemiology of HF in some
African and tropical countries [4, 6, 8–11]. The reasons
for sex and age bias for HF could be because, at least in
our settings, young girls and boys are culturally engaged
as drawers of domestic water for house hold use. This
practice would expose them more frequently to infection
with HF than would adults. At TotalCare Medical
Centre, records also indicated that there were more
women and young children who visited the health centre
than adult males.
Laboratory investigations including bilirubin levels in-
dicated elevated serum and urinary bilirubin which is in
agreement with findings by other studies on HF [7, 24].
Examination of blood films showed that most patients
had marked eosinophilia, which is also of value in the
diagnosis of HF during the acute phase of the disease
[24]. Clinically, fascioliasis patients present with fever
and malaise, urticaria and swelling of lips during the
acute stage of disease. In this study, pain at the upper
right abdominal quadrant was a common clinical finding
in most of the patients whose stools were found positive
for Fasciola eggs. Pruritis was also reported by some of
the patients and swelling of the lips was also seen. The
latter three findings have also been described by other
studies [7] as common findings associated with HF in
the chronic, patent phase of the disease.
Conclusions
The challenges associated with a definitive diagnosis of
human fascioliasis, especially at the clinical level are
many: First, eggs are never passed in stool during the
acute phase of the disease, therefore patients presenting
clinically are likely to be missed on routine stool screen-
ing especially if only a single sample is examined without
concentration. Clinical symptoms are also usually less
pronounced in subsequent infections [3, 5, 24]. Much of
the symptomatology presented in this study was further
confounded by other infections diagnosed and cannot
definitively be attributed to fascioliasis, even where eggs
were found in patients’ stools.
Secondly, although we examined at least 2 samples per
patient, we used only a qualitative concentration/sedi-
mentation method as these screenings were not preju-
diced towards the detection of Fasciola eggs alone. No
quantification was done nor were any methods
employed for the purpose. Other intestinal parasites
were often diagnosed and consequently managed before
specific screening for fascioliasis was started. Lastly, the
definitive diagnosis of fascioliasis by species is usually
based on the use of specific coprologic antigen tests or
molecular analysis [11–15]. This study was conducted
in-house in a primary health centre where neither of
these diagnostic options were available, nor have they
been approved for use in the country and region to date.
Human fascioliasis has not been hitherto reported from
Tanzania or any other East African country. Subsequent
studies could focus on this distinction and make further
clinical associations once the disease has been recog-
nized as a significant public health problem.
This study serves as a reminder to the medical profes-
sion in East Africa that HF, a food borne trematode in-
fection, is probably of more common occurrence than
has hitherto been realized.
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